Peer Review, UGC Care
ESTIMATION OF AROMATASE ENZYME IN OBESE INFERTILE MEN
View PDF

Keywords

Aromatase enzyme, Male infertility, Obesity.

How to Cite

Ula M. AL-Kawaz, AL-Ani, N. K. ., & Wassef, H. F. . (2015). ESTIMATION OF AROMATASE ENZYME IN OBESE INFERTILE MEN. International Journal of Research and Development in Pharmacy & Life Sciences, 4(6), 1820-1826. Retrieved from https://ijrdpl.com/index.php/ijrdpl/article/view/422

Abstract

Male obesity is associated with physiological changes that can negatively affect male fertility. Obese men have demonstrated a 3-fold increase in the prevalence of oligozoospermia when compared with men with normal Body Mass IndexBMI .The experiment was conducted to find the correlation between Aromatase enzyme and FSH, LH, E2 , testosterone and BMI.

Seventy obese infertile male (patients) and twenty obese fertile male (control) are enrolled in this study. Aromatase enzyme, FSH, LH, E2 and testosterone hormones were measured in their serum.Median human cytochrome enzyme level was significantly higher in patients than in control group, 87.55 versus 56.95, (P= 0.014). In patients group, a significant positive correlation was found between human cytochrome enzyme, FSH and LH. The present study showed  clearly that male obesity negatively impacts fertility through changes in hormone levels. The results suggest that increased estrogen as a result of aromatization in the fatty tissue, reflected through the increase in human cytochrome enzyme (aromatase), may be an important mechanism for the hypoandrogenemia and altered sperm parameters.

View PDF

References

Hammoud, A. O., Gibson, M., Peterson C. M., et al. "Obesity and male reproductive potential". J. Androl. 2006; 27, 619–626.

Cheng, J. Y. & Ng, E. M. "Body mass index, physical activity and erectile dysfunction: an U-shaped relationship from population based study". Int. J. Obes. 2007; 31, 1571–1578.

Globerman, H., Shen-Orr, Z., Karnieli, E., et al." Inhibin B in men with severe obesity and after weight reduction following gastroplasty". Endocr. Res. 2005;31, 17–26.

Simpson ER, Mahendroo MS, Means GD, at el. "Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis". Endocrine Reviews 1994; 15, 342–355.

Simpson ER."Aromatase: biologic relevance of tissue specific expression". Semin Reprod Med. 2004; 22:11–23.

Francisco Urbanos, Juan Fernandez-Baeza & Bruno Chaudret. "Selective aromatization of the A ring of steroids through demethylation by an Soc., Chem. Commun. 1991; 1739-1741.

Swan, S. H., Elkin, E. P. & Fenster, L. "The question of declining sperm density revisited: an analysis of 101 studies published 1934– 1996. Environ. Health Perspect. 2000; 108, 961–966.

Hofny, E. R., Ali, M.E., Abdel-Hafez, H.Z., et al. "Semen parameters and hormonal profile in obese fertile and infertile males". Fertil. Steril. 2010; 94, 581-4.

Aggerholm, A. S., Thulstrup, A. M., Toft, G., et al. "Is overweight a risk factor for reduced semen quality and altered serum sex hormone profile?" Fertil. Steril. 2008; 90, 619–626.

Padubidri, VG; Daftary, SN, eds. "Shaw's Textbook of Gynaecology". 2011; (15th ed.). p. 201.

L. Gennari, R. Nuti, & J. P. Bilezikian, “Aromatase activity and bone homeostasis in men,” Journal of Clinical Endocrinology and Metabolism, 2004; vol. 89, no. 12, pp. 5898–5907.

W. de Ronde, H. A. P. Pols, J. P. T. M.et al."The importance of oestrogens in males,” Clinical Endocrinology, (2003) vol. 58, no. 5, pp. 529–542.

E. Simpson, M. Jones, S. Davis, et al. “Do intracrine mechanisms regulate aromatase expression?” Journal of Steroid Biochemistry and Molecular Biology, 1999; vol. 69, no. 1–6, pp. 447–452

F. Labrie, A. Bélanger, L. Cusan, et al “Physiological changes in dehydroepia- ndrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology,” Journal of Clinical Endocrinology and Metabolism, 1997; vol. 82, no. 8, pp. 2403–2409.

T. Yanase, Y. M. Mu, Y. Nishi, et al. “Regulation of aromatase by nuclear receptors,” Journal of Steroid Biochemistry and Molecular Biology, 2001; vol.79, no. 1–5, pp. 187–192.

Y. M. Mu, T. Yanase, Y. Nishi, et al. “Combined treatment with specific Ligands for PPARγ:RXR nuclear receptor system markedly inhibits th expression of cytochrome P450arom in human granulosa cancer cells,” Molecular and Cellular Endocrinology, 2001; vol.181, no. 1–2, pp.239– 248.

MacDonald AA, Herbison GP, Showell M, et al. "The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with meta-analysis". Hum Reprod Update, 2010; 16(3):293–311.

Hajshafiha, M., Ghareaghaji, R., Sadeghi- Bazargani, H at el. "Association of body mass index with some fertility markers among male partners of infertile couples".Int. J. Gen. Med 2013; 6, 447-451.

Al-Ali, B.M., Gutschi, T., Pummer, K., at el. "Body mass index has no impact on sperm quality but on reproductive hormones levels". Andrologia.2014; 46(2), 106–111.

Qin DD, Yuan W, Zhou WJ, et al. "Do reproductive hormones explain the association between body mass index and semen quality?" Asian J Androl. 2007; 9(6):827–34.

Bulun SE, Sebastian S, Takayama K. at el. "The human CYP19 (Aromatase P450) gene: update on physiologic roles and genomic organization of promoters". J Steroid Biochem Mol Biol. 2003; 86:219– 224.

De Boer H, Verschoor L, Ruinemans-Koerts J, at el."Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism". Diabetes Obes Metab 2005; 7 (3) 211- 215.

Schneider G, Kirschner MA, Berkowitz R.at el. "Increased.estrogen production in obese men". J Clin Endocrinol Metab.1979; 48 (4) 633-638.

Akingbemi BT." Estrogen regulation of testicular function". Reprod Biol Endocrinol .2005; 3: 51.

Pauli, E.M., Legro, R.S., Demers, L.M., at el. "Diminished paternity and gonadal function with increasing obesity in men". Fertil Steril. 2008; 90(2):346-51.

Egwurugwu1, J.N., Nwafor, A., Chike, C.P.R., at el. "The relationship between body mass index, semen and sex hormones in adult male". Nig. J. Physiol. Sci. 2011; 26, 29 –34.

Roth, M. Y., Amory, J. K. & Page, S. T. "Treatment of male infertility secondary to morbid obesity". Nat. Clin. Pract. Endocrinol. Metab. 2008; 4, 415–419.

Foresta C, Di Mambro A, Pagan C, at el." Insulin- like factor 3 as a marker of testicular function in obese men". Clin Endocrinol. 2009; 7,422-426.

Tsai, E. C., Matsumoto, A. M., Fujimoto, w. Y. et al. "Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat". Diabetes Care. 2004; 27, 861–868.

Strain, G. W. "Mild hypogonadotropic hypogonadism in obese men". Metabolism. 1982; 31, 871–87

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Copyright (c) 2020 Array

Downloads

Download data is not yet available.